Advertisement

 

 

Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans.

Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans.
Author Information (click to view)

Kazi DS, Lu CY, Lin GA, DeJong C, Dudley RA, Chen R, Tseng CW,


Kazi DS, Lu CY, Lin GA, DeJong C, Dudley RA, Chen R, Tseng CW, (click to view)

Kazi DS, Lu CY, Lin GA, DeJong C, Dudley RA, Chen R, Tseng CW,

Advertisement

JAMA cardiology 2017 09 13() doi 10.1001/jamacardio.2017.3051
Abstract

Submit a Comment

Your email address will not be published. Required fields are marked *

2 + three =

[ HIDE/SHOW ]